[AKRO] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
29-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -39.15%
YoY- -169.40%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 284 0 0 0 0 0 0 -
PBT -55,186 -23,059 -32,424 -29,711 -15,611 -61,472 -960 96.39%
Tax -12,527 -2,574 -11 -11 -46 -2,968 0 -
NP -55,186 -20,485 -32,424 -29,711 -15,611 -61,472 -1,026 94.22%
Tax Rate - - - - - - - -
Total Cost 55,470 20,485 32,424 29,711 15,611 61,472 1,026 94.39%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -19,431.69 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.99 -0.44 -0.93 -0.86 -0.55 -2.90 -4.54 -22.40%
EPS Diluted -0.99 -0.44 -0.93 -0.86 -0.55 -2.90 -4.53 -22.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.